This compound is a hydrochloride salt of Fmoc-protected L-lysine, commonly used as a building block in solid-phase peptide synthesis. Its significance lies in the Fmoc (9-fluorenylmethoxycarbonyl) group, which temporarily protects the amino group during peptide chain assembly.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 139262-23-0
Fmoc-L-lysine
pharmaceutical intermediate
Benzyl (2S)-6-amino-2-(9H-fluoren-9-ylmethoxycarbonylamino)hexanoate;hydrochloride
pharmaceutical intermediate
N-fmoc-L-norleucine
research compound
2-Methoxy-2-oxoethyl [2-(2,6-dichloroanilino)phenyl]acetate
pharmaceutical intermediate
2-Ethoxy-2-oxoethyl [2-(2,6-dichloroanilino)phenyl]acetate
pharmaceutical intermediate
Aceclofenac Tert-Butyl Ester
pharmaceutical intermediate
1-Boc-4-[methoxy(methyl)carbamoyl]piperidine
pharmaceutical intermediate
N2-[(9H-Fluoren-9-ylmethoxy)carbonyl]-D-lysine hydrochloride
pharmaceutical intermediate
(2S)-6-amino-2-(9H-fluoren-9-ylmethoxycarbonylamino)hexanoic acid;hydrochloride
MVMZFAIUUXYFGY-FYZYNONXSA-N
C1=CC=C2C(=C1)C(C3=CC=CC=C32)COC(=O)N[C@@H](CCCCN)C(=O)O.Cl